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ignaling pathways that are activated
upon interaction of glial cell-line
derived neurotrophic factor (Gdnf), its
coreceptor Gfrα1 and receptor tyrosine
kinase Ret are critical for kidney development and ureter maturation. Outside the
kidney, this pathway is implicated in a
number of congenital diseases including
Hirschsprung disease (intestinal aganglionosis, HSCR) and hereditary cancer
syndromes (MEN 2). Total lack of Gdnf,
Gfrα1 or Ret in mice results in perinatal
lethality due to bilateral renal agenesis
or aplasia. In humans, RET mutations
have been identified in a spectrum of
congenital malformations involving the
RET axis including isolated HSCR, isolated congenital anomalies of kidney or
urinary tract (CAKUT) or CAKUT and
HSCR together. The molecular basis for
these pleiotropic effects of RET has just
begun to be unraveled. In an effort to
delineate the pathogenetic mechanisms
that underlie these congenital malformations, we and others have characterized
Ret’s role in early kidney and urinary
system development. Here we present a
brief overview of the many faces of Ret
dysfunction in kidney with particular
emphasis on Ret’s signaling specificity
and intergenic interactions that confer
normal urinary system development.
Clinical Aspects of Congenital
Urinary Tract Anomalies
Congenital anomalies of kidney or lower
urinary tract (CAKUT) are common
anomalies (1 in 250 live births) and the
most common cause of renal failure in
children.1 These include renal hypoplasia/
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dysplasia,
agenesis,
hydronephrosis,
megaureter/hydroureter, duplicated collecting system, abnormal valves and distal obstruction. The abnormalities can
occur in isolation, or as a complex, or as
a part of other syndromes involving multiple organ systems. In some cases they are
incompatible with life and even after surgical correction, many patients progress to
renal failure or have associated comorbidities that include skeletal, cardiovascular
and hematopoeitic systems. Thus, there
is considerable interest in understanding molecular genetics of CAKUT and
related diseases. In many respects, rodent
kidney development is similar to human
kidney development. For example, kidney development in both occurs in an
anterior to posterior direction in three
stages, pronephros, mesonephros and
metanephros (see below). Further, several
genes have been identified that regulate
kidney development in both humans and
rodents. Among these alterations, mutations in RET, a receptor tyrosine kinase
(RTK), were recently found in about 35%
of patients with various forms of renal
agenesis.2 In an effort to better understand
how RET might lead to CAKUT, several
laboratories have characterized Ret mutant
animal models and deciphered the various processes during mammalian kidney
development that depend on Ret, and in
doing so have provided valuable insights
into kidney organogenesis and CAKUT
pathogenesis. Today I will provide a brief
overview of the diverse roles of Ret pathway in early kidney development with particular emphasis on insights gleaned about
the basis for signaling specificity from animal models.
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Urinary System Development
There are three pairs of embryonic kidneys that develop in mammals in an anterior to posterior direction: the pronephros,
mesonephros and metanephros.3 First, the
pronephros develops from a collection of
cells in the intermediate mesoderm (IM)
that undergo mesenchymal to epithelial
transition and initiate the development
of nephric duct (Wolffian duct, WD)
(in mice at about E8.5d; in humans at 3
weeks of gestational age). The pronephros is a transient, nonfunctional structure that is followed by another transient
structure, the mesonephros (at about E9d
in mice; about 25d gestation in humans).
The mesonephros contains a linear organization of nephrons along the growing
WD. In mice only the rostral/anterior
mesonephric tubules are connected to
the WD. These later become part of the
epididymis in males. The WD becomes
the vas deferens.
Development of the definitive kidney or metanephros in mice begins at
E10.5-E11.5 as an outgrowth from the
WD known as ureteric bud (UB, future
collecting system).4,5 Specific signals from
the metanephric mesenchyme (MM) regulate UB outgrowth into MM, a process
called induction. Upon reaching the MM,
the UB tip undergoes branching morphogenesis to form the collecting system. The
initial UB stalk becomes the ureter. The
branching UB tips reciprocally induce the
surrounding mesenchyme (causing mesenchymal condensation), a process that
stimulates nephrogenesis. At the same
time, equally important events occur in
the distal WD and the ureter that determine proper connection of the ureter to
the bladder. The ureter undergoes remodeling which involves separation from
the WD (future genital duct in males),
insertion and migration into the trigone
accompanied by common nephric duct
(CND) degeneration.6 Abnormal ureteral
maturation results in megaureter, hydronephrosis, vesico-ureteral reflux, ureteropelvic junction (UPJ) abnormalities and
obstruction, while abnormal UB induction results in renal agenesis, hypoplasia
or dysplasia. More severe abnormalities
in these processes will present in utero or
early childhood and many result in renal
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failure in children. Less severe abnormalities such as mild hypoplasia (suggesting
reduced branching morphogenesis and
nephrogenesis) may remain undetected by
conventional screening procedures, and
may result in hypertension and chronic
renal failure.
Diseases Associated with RET
RET is an acronym for “rearranged during
transfection.” It was discovered as a generearrangement that resulted in transformation of NIH3T3 fibroblasts when human
lymphoma DNA was transfected into these
cells.7 RET encodes a single pass, transmembrane receptor tyrosine kinase (RTK)
that resides at chromosome 10q11.2 in the
human genome.8 It consists of 20 exons
with a potential to generate two major isoforms due to alternative splicing in the carboxy terminus (Fig. 1) (see below).9 RET
homologues exist in all vertebrates and
have also been identified in Drosophila melanogaster. RET mutations have been identified in several human diseases. Activating
RET mutations predispose to hereditary
oncogenic syndromes such as multiple
endocrine neoplasia type 2 (MEN2), are
present in 30–70% of sporadic medullary
thyroid carcinomas, and have been identified in papillary thyroid carcinomas. More
recently RET and estrogen receptor pathway interaction was shown to be important in development of breast cancer.10
Inactivating RET mutations are a predominant feature of hereditary Hirschsprung
disease (HSCR, intestinal aganglionosis)
and also found in a large number of sporadic HSCR.11 Majority of gain and loss
of RET phenotypes known to date present
in an autosomal dominant manner. RET
mutations have been reported in patients
presenting with MEN2 and HSCR,
CAKUT and MEN2, and more recently
in patients with isolated CAKUT, or with
HSCR and CAKUT.2,12,13 These observations illustrate the potential for aberrations
in RET signaling to predispose for both
isolated as well as multisystem defects in
urinary and other systems. They have led to
increased efforts to understand the mechanisms of RET function at cellular as well as
at organ level in hopes of delineating how
abnormalities of RET signaling can be
associated with multiple syndromes.
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Gross Anatomy of RET
RET consists of three main domains,
extracellular, transmembrane and cytoplasmic.14 The extracellular domain
plays a role in receptor dimerization and
interaction with one of its coreceptors
and ligand (Fig. 1). While the predicted
molecular mass of RET is 150 kDa, glycosylation in the amino-terminus results
in an approximately 170 kDa mature protein. The tyrosine kinase domain resides
in the cytoplasmic portion. There are two
major isoforms of RET, RET9 (1072aa)
and RET51 (1114aa). These are generated
by alternative splicing in the 3-prime (3')
region of RET such that the carboxy terminus of the mature protein is identical
until residue 1063. Thus RET9 has nine
amino acids in the carboxy terminus that
are different than the 51 terminal residues
in RET51.
GDNF-GFRα1-RET Signaling
Glial cell line-derived neurotrophic factor
(GDNF) family ligands (GFLs) are a family of four neurotrophic factors, GDNF,
Neurturin, Artemin and Persephin
(Fig. 1B). Interaction of a homodimer of
one of the GFLs with a homodimer of one
of their preferred coreceptors (GFRα1-4),
increases affinity of GDNF-GFRα1 to
interact with a RET homodimer.15 This
results in a multicomponent activated
receptor complex leading to phosphorylation of key tyrosine (Y) residues in the
cytoplasmic domain. RET-Y905 is a site
necessary for kinase activity and modulates autophosphorylation of four key
docking tyrosines that serve as binding
sites for intracellular adaptors leading to
activation of major signaling pathways.
Activation of these pathways determines
the type of biological response to be
elicited in a cell. RET-Y905 regulates
binding to Grb7/10, RET-Y981 binds to
SRC, RET-Y1015 to PLCγ, and RETY1096 which is only present in RET51,
to GRB2. Further, RET-Y1062 serves as
a multidocking adaptor site for several
intracellular adaptors including SHC,
FRS2, IRS1/2, DOK1, DOK4-6 and
ENIGMA (Fig. 1C). Phosphorylation
at RET-Y1062 enables binding to adaptors like SHC to activate PI3K/AKT or
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Figure 1. Ret gene structure and signaling. (A) Gene structure of RET. RET is located at chr 10q11.2 and consists of 20 exons (rectangular boxes).
Depicted are two major RET isoforms, RET51 and RET9, generated by alternative splicing. (B) Diagram showing RET activation by glial cell line-derived
neurotrophic factor (GDNF) family ligands (GFLs). A dimer of one of the four GFLs (GDNF; Neurturin, NRTN; Artemin, ARTN; Persephin, PSPN)
associates with homodimers of one of the four GPi-linked corereceptor’s (GFRα1-4) to form multimeric complex with a RET homodimer. This leads
to activation of RET kinase domain in the cytoplasmic side by phosphorylation, and downstream signaling cascades that regulate the indicated biological responses. (C) Gross anatomy of RET. Different RET domains are shown, extracellular, transmembrane (TM) and cytoplasmic domain that
harbors the kinase activity regions. Key RET tyrosine (Y) residues, the preferred intracellular adaptors that they bind to, and the downstream signaling
cascades that are activated are shown. Y905 is a residue important for RET kinase activity. Note the extra Tyr Y1096 in the RET51 isoform directly
binds to GRB2 to preferentially activate PI3K/AKT pathway. Thus, both RET-Y1062 and RET-Y1096 can activate PI3K through GRB2-GAB1/2.

MAPK cascades through recruitment of
GRB2/GAB or GRB2/SOS, respectively.
The PI3K/AKT pathway can also be
activated by direct recruitment of GRB2GAB complex on phospho-RET-Y1096
present in RET51. The major pathways
activated by SRC and PLCγ are RAS-
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MAPK and PKC, respectively. These
pathways regulate cellular processes such
as proliferation, migration, survival and
regeneration in a number of tissue specific stem cells/progenitors including the
spermatogonial stem cells, enteric neural
crest precursors, CNS and PNS neurons,
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and in the embryonic kidney (metanephros).16 One active area of investigations
is deciphering the biological need for the
various RET isoforms and the signaling cascades in kidney development and
disease. Do they provide redundancy or
specificity?
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Figure 2. Ret expression in early developing murine kidney. Cartoon shows Ret expression in relation to early stages of embryonic (E) murine kidney
development. Wolffian duct (WD) is represented as vertical tube, ureteric bud (UB) as an outgrowth from caudal end of WD, common nephric duct
(CND) at distal end of WD, and metanephric mesenchyme (MM) expressing Gdnf as red oval. Ret is first detected at E8.5 in cellular aggregates in the
pronephros, then continues to be expressed in the growing WD during mesonephros development, albeit at lower levels. Intense Ret expression is
seen at the beginning of metanephric kidney at distal end where UB develops at E10.5. When UB reaches MM (at E11.5), first branching event occurs
and intense Ret expression is observed in the tips of the UB. As branching continues, strong Ret expression is confined to UB tips, and Ret expression
in WD becomes almost undetectable except in the CND, and becomes weaker in the UB stalk. The intensity of blue correlates with Ret expression.

Gdnf-Gfrα1-Ret Expression in the
Kidney and Lower Urinary Tract
Much of our understanding of the role of
Ret signaling pathway in kidney development and function comes from the
knowledge of spatio-temporal expression
patterns of Ret signaling components in
conjunction with phenotypic analysis of
various Gdnf/Gfrα1/Ret mutant mice.
Using in situ hybridization or analysis of
reporter mice that express lacZ or green
fluorescent protein (GFP) from Ret or
Gfrα1 loci we have detected Ret and
Gfrα1 expression in the developing WD
in the pronephric kidney as early as E8.5d
in mice (Fig. 2) (data not shown). Before
UB budding at E10.5, increased Ret
expression is detected in the distal WDs
suggesting its role in UB induction.17-19 In
mice, expression of Gdnf from the MM
at about E10.5 activates Gfrα1-Ret signaling in the WD to promote UB outgrowth
into the MM and subsequent branching morphogenesis.20 During branching
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morphogenesis, Gdnf expression becomes
more localized to the undifferentiated
mesenchyme in the periphery and it is
markedly reduced or undetectable in the
mature kidney.4 The postnatal expression
of GFLs is poorly defined in the kidney.
Among the other GFLs, Neurturin is also
expressed in the UBs of embryonic kidney after E14. However, its physiological
relevance is not known as Neurturin null
animals have normal kidneys.17,21 In the
initial stages of metanephric kidney development both Ret and Gfrα1 are expressed
in the ureteric bud stalk and the UB tip.
During branching morphogenesis Ret and
Gfrα1 expression diminishes in the UB
stalk and their expression is more confined
to proliferating UB tip cells. Towards the
later stages of kidney development, high
expression of both these genes is seen in
the nephrogenic zone. Postnatal expression
of Ret and Gfrα1 is less defined, although
our recent observations using Gfrα1 and
Ret reporter mice detect Ret and Gfrα1 in
collecting ducts, with weaker expression
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in older mice (unpublished observations).
Interestingly, Gfrα1 expression in the kidney is broader than Ret as it is also detected
in the cap mesenchyme surrounding the
branching UB tips and in a subset of cortico-medullary proximal tubules in adult
kidneys (unpublished observations).20,22,23
Gfrα1 expression in structures that do
not express Ret has been attributed to
Ret-independent roles or in trans-Ret activation.24 Although, trans expression is dispensable for normal kidney development,
it may have unrecognized roles in adult
kidney under pathological conditions.23
Biological Roles of
Gdnf-Gfrα1-Ret in Kidney
Development
Consistent with these expression patterns
of Gdnf, Gfrα1 and Ret in the developing kidney, gene knock-out studies reveal
that this pathway is essential for early kidney development as the absence of Gdnf,
Gfrα1 or Ret during embryogenesis in
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mice results in renal agenesis/rudimentary kidneys and perinatal lethality.18,25-29
Several findings suggest that Ret signaling
also has a role in later kidney branching
morphogenesis. These include expression
of Ret signaling components in later kidney development, inhibition of branching in vitro using Ret-activated pathway
inhibitors and dependence of branching
on stimulating or inhibiting Gdnf.30-32
However, direct proof for Ret’s role postUB induction in vivo would require its
conditional inactivation after early UB
induction has occurred.
The agenesis phenotype in Gdnf/
Gfrα1/Ret null animals suggested a role in
early UB induction and growth. A series of
innovative studies to illuminate Ret’s role
at a cellular level in orchestrating branching morphogenesis were undertaken by Dr.
Costantini’s laboratory. Chimeric animals
were generated in which “trackable” Retnull cells and wild-type cells contributed
to the kidney. It was observed that during branching these Ret-null cells never
populated the UB tip, showing that intact
Ret signaling is required for populating
the UB tip.33 More recently, in a similar
series of experiments it was shown that Ret
activity was necessary to modulate WD
epithelial cell rearrangements at the distal
WD prior to UB budding.34
To determine if Gdnf in MM provides
tropic cues to the UB to reach the MM
and branch, Shakya et al. expressed Gdnf
exclusively in the WD by expressing Gdnf
under the regulation of HoxB7 promoter
in the background of Gdnf null mice.35
They observed that generalized expression of Gdnf only in WD and the urinary
tree was able to support metanephric kidney development. However, ectopic UBs
also develop, indicating that expression of
Gdnf in MM is not necessary for the UB
to reach the MM and undergo branching morphogenesis. This suggests that
there are redundant cues in MM for UB
tropism.
Gdnf, Gfrα1, Ret Signaling in the
Lower Urinary Tract
Formation of the ureterovesicular junction
is a critical event in ensuring the proper
union and communication between the
upper (derived from WD) and lower
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Figure 3. Hypomorphic Ret allele provides evidence that varied Ret signaling is associated with
different CAKUT manifestations. (Top row), Compared with wild-type (wt) mice, RetDN/+ mice (express a Ret form with severely reduced, but not absent, Ret-Y1062 signaling) showed a spectrum
of renal defects including bilateral small kidneys and unilateral renal agenesis (k, kidney; a, adrenal;
ub, urinary bladder, t, testis; o, ovary; adrenal gland, arrowhead). (Bottom row) Bar graph shows
decreased total number of glomeruli in Ret DN/+ kidney at birth (n = 3 animals, 5 kidneys) compared
with wild-type litter mates (n =3 animals, 6 kidneys) (*p < 0.001, mean ± s.e.m). H&E-stained sections show tubulocystic degeneration (arrows) in approximately 50% of 3- to 4-week-old Ret DN/+
mice (6 of 12) (co, cortex; me, medulla; pe, pelvis). Scale bar = 5 mm in top row, and 600 μm in
bottom row. The figure is adapted from Jain et al.40 with permission.

urinary tracts (cloaca). It requires that distal portion of WD inserts normally in the
cloaca (by E10.5), followed by CND degeneration (by E14.5), ureter separation from
the WD and its migration into the trigone
to connect to the bladder lumen.6,36,37
Defects in this process can result in failure
of the ureter to connect or traverse through
the bladder and induce reflux nephropathy.
In children this is one of the most common causes of renal failure. Degeneration
of the CND is a critical event for proper
connection of the upper and lower urinary tracts and development of the male
genital tract. Ret expression in the CND
is markedly increased at E11.5 and both
Ret and Gfrα1 are expressed in the CND
until CND degenerates by E14.5. Gdnf is
expressed in the surrounding urinary bladder wall. Consistent with this expression,
a number of ureter abnormalities are present in Ret-null mice and include unilateral/bilateral ureter agenesis, blind ending
ureters and failure to connect to the urogenital sinus.6,18 These studies suggest that
Ret is likely involved in promoting CND
apoptosis and ensuring proper connection of the upper and lower urinary tracts.
While upstream pathways such as retinoic
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acid receptor signaling positively regulate
Ret in ureter maturation6,36 it was reported
recently that members of the LAR family
of protein tyrosine phosphatases negatively
regulate Ret signaling in the formation of
UVJ by controlling distal ureter apoptosis.38 Because UVJ abnormalities are a
major cause of CAKUT, it is important
to delineate specific pathways emanating
from Ret or the CND niche that regulate
ureter remodeling.
Insights into CAKUT from Animal
Models with Altered Ret Signaling
While studies performed using Gdnf,
Gfrα1, Ret null mice revealed an absolute
requirement for Ret signaling in kidney
development it wasn’t until Ret-mutants
with severely diminished signaling were
characterized that a wider role of Ret in
kidney development was defined. One of
these mutants expressed a Ret hypomorphic allele that in homozygous state causes
intestinal aganglionosis and hypoplastic,
cystic kidneys.39 Another example is a
mouse that expresses a Ret dominant negative allele, that severely diminishes signaling through Ret-Y1062 (Shc binding site
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and activate PI3K/MAPK pathway).40
This mouse presents with varying degrees
of abnormal kidneys including bilateral
hypoplasia, unilateral hypoplasia and unilateral agenesis (Fig. 3). Many of these mice
survive for several weeks postnatally and
a subset of the mice develops renal cysts.
Eventually these mice fail to thrive and die
due to varying degrees of small and large
bowel aganglionosis. Results from these
studies not only created useful animal disease models, but also provided a glimpse
of wider roles of Ret pathways in kidney
development especially insights into how
varying activities of Ret are associated
with a spectrum of renal malformations,
Ret’s potential role in postnatal collecting
duct cystic abnormalities, and how differential Ret activity can impact development
of the urinary and other systems.
While my lecture focused on Ret and
downstream signaling in kidney development, it should be noted that several factors such as Eya1, Sal1, Pax2, Six2, Wnt11
or Gdf11 can also modulate Ret signaling
and influence kidney branching by altering Gdnf expression in the mesenchyme or
by modulating the availability of Gdnf to
Ret such as by 2-O sulfation.5,41 Animals
with mutant forms of these genes present
with a range of kidney defects due to aberrant Ret signaling.
The Role of Specific Ret-Activated
Pathways in CAKUT Pathogenesis
Ret activates several major signaling cascades and exists in at least two major isoforms. To ascertain whether each makes
an incremental contribution towards UB
induction, or whether each has a specific
role, we and others have undertaken studies to examine the impact of individual Ret
pathway mutants and isoforms on organogenesis. One of the questions examined
was the biological relevance of the extra
Grb2 docking site that preferentially activates PI3K/AKT pathway in the Ret51
isoform. Two groups pursued this question
by characterizing mice that express exclusively either the Ret9 or Ret51 isoform.
Interestingly, quite different results were
obtained. A mouse expressing only Ret51
where Ret51 was a chimeric form consisting of mouse extracellular-human cytoplasmic domain was not able to fully support
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normal kidney or ENS development.39 This
suggests that the carboxy-terminus of Ret51
perhaps has an inhibitory role that could be
either due to the different nine residues in
the two isoforms or due to the additional
Grb2 binding site. In contrast, when mice
were made that exclusively express human
wild-type RET9 or RET51 isoforms, it
was found that either isoform is competent for proper kidney development.42
Further, mice in which the nine residues
after RET1063 in RET9 and RET51 were
swapped also did not manifest differences
in kidney development. This suggests that
the extra or different residues in carboxyterminus between RET9 and RET51 are
of no significance for normal development
and that the portion of RET51 containing
the Grb2 binding site is dispensable.42 The
reasons for the different results between the
two groups are not entirely clear. However,
the findings raise the possibility that in
different contexts the isoforms could have
redundant or unique roles.
To examine the biological roles of each
of Ret’s major tyrosine adaptor docking
sites mice were made that transduce signals from all docking sites except one.42
This was accomplished by the generation
of mice that only express mutations (TyrPhe) in Src, Plcγ or Shc adaptor sites or
that lack the carboxy terminal 43 residues
in RET51 with the Grb2 site. The results
show that only the Plcγ mutants (RET51Y1015F) were not able to support proper
kidney development (Fig. 4). In fact, abrogation of the Plcγ site resulted in a quite
complex CAKUT phenotype with bilateral
megaureters, hypoplastic and dysplastic
multicystic kidneys, failure of separation
of gonadal duct from the ureter leading
to attachment of gonads to the urinary
tree in both males and females, and possibly distal ureter abnormalities (Fig. 5).
Characterization of these mutants during
embryogenesis revealed that the phenotype
is partly related to presence of supernumerary ureters and partly due to branching
defects. However, additional studies during
mesonephric and early metanephric kidney
development will likely provide insights
into the developmental basis for these
results including defining whether UB
sprouts from the right position, and problems associated with mesonephros degeneration, insertion of WD into cloaca and
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CND degeneration. This new phenotype
associated with abrogation of only one specific signaling cascade defines yet another
role of Ret in CAKUT that could not have
been realized by knockout studies.
To further explore whether redundant signaling from Grb2 masks essential
roles of the Src or the Shc adaptor site,
mice with mutations in Plcγ, Src and Shc
binding sites were made in context of the
RET9 isoform.42 The results in general
show that the Grb2 containing carboxy
terminus provides redundancy to both
the Src (RET9-Y981F) and multidocking
Shc (RET9-Y1062F) sites, although the
impact at these sites appear to be different.
For instance, the RET9-Y981F mutants
show incomplete penetrance of CAKUT
with only a subset harbor megaureters.
On the other hand loss of Shc binding in
the face of absent Grb2 resulted in phenotype quite similar to Ret-null mice,
bilateral agenesis or kidney rudiments
(Fig. 4). The same result was also seen
in mice expressing a chimeric Ret9Y1062F allele made by fusion of mouse
Ret extracellular and human Ret intracellular domains.43 A different approach
to examine the role of the Shc binding
site was taken by creating this mutation in
the endogenous mouse Ret (i.e., it would
express this mutation in both Ret9 and
Ret51). This resulted in slightly hypoplastic kidneys.44 Together these studies suggest that Grb2-mediated signals provide
redundancy to Src and Shc binding sites
and totally abrogating Grb2 (through Shc
or direct Grb2 binding) is the reason for
agenesis in Ret-null mice. Interestingly,
the role of Grb2 on the Src site in kidney
development seems to be different than
on the Shc site as Ret-Src mutants show a
megaureter phenotype as opposed to agenesis typically seen in all Ret9 mutants deficient in Shc binding. These animal models
provide remarkable insights into specificity of Ret-activated signaling cascades that
determine the manifestation of different
types of CAKUT.40,42-44
Genetic Interactions of Ret
Signaling Complexes that
Influence Kidney Development
Both positive and negative regulators
influence kidney development. These
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Figure 4. For figure legend, see page 184.
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Figure 4. Roles of Ret isoforms and downstream cascades in kidney development. (A) Schematic of the different wild-type RET9, RET51 and their
respective mutant knocked-in alleles. The different domains and sizes of the RET9 and RET51 alleles are indicated. The red and blue colors represent
the area of divergence between the two RET isoforms. Also indicated are the key docking tyrosine (Y) residues. Homozygous mice were generated
that harbor Tyr→Phe (Y→F) for each of the indicated Tyr except Y1096. RET51(Cdel) is an allele where residues 1063–1072 of RET9 were replaced
with residues 1063–1072 of RET51 (results in receptor that is essentially similar to RET51 with deletion of residues 1073–1114, including Y1096).
RET9(51C) is an allele where residues 1063–1072 of RET51 were replaced with residues 1063–1072 of RET9 (results in a receptor that is essentially
similar to RET9 with C-terminus of RET51 including Y1096). (B) Hematoxylin-Eosin-stained kidney sections of homozygous mice for the indicated
knocked-in alleles at P0. Left column shows all the mutants in the context of RET51 isoform, and the right column in RET 9 context. Note wild-type
forms of RET9 and RET51 have redundant functions in kidney development. Except for RET-PLCγ mutant RET51(Y1015F) individual abrogation of the
key docking sites was dispensable. However, these same docking sites show dramatic kidney defects when the C-terminal Grb2 binding site is also
deleted (mutations in RET9 context). Without Src and Grb2, there was a partially penetrant megaureter (see Fig. 7); without PLCγ (individually or
without Grb2 site) kidneys are small and show cysts and dysplasia; without Shc and Grb2 (RET9-Y1062F), only kidney rudiments or agenesis is seen.
Thus direct Grb2 binding site provides some redundancy to Y981 and Y1062 docking sites in kidney development. In these studies, swapping the 10
residues following 1063aa between the two isoforms did not appear to influence kidney development suggesting that differences in the isoforms are
not due to these regions. Adapted and modified from Jain et al.42 with permission.

Figure 5. Complex CAKUT phenotype RET51(Y1015F) due to supernumerary ureters and decreased branching. (A) Histological and gross features
of RET-Y1015F-PLCγ signaling mutant. The H&E-stained pictures at P0 show cystic hypodysplastic kidney (left), dilated ureters and possible distal
stricture (middle) and failure of testes to separate from the urinary system (right). The gross photograph shows massive megaureter/hydroureter and
barely any recognizable kidney parenchyma in 4 week old RET(Y1015F) mutant mice. (B) Whole mount Dolichos Biflorus Agglutinin-FITC (DBA-FITC)
staining of E15.5 kidneys. Top: Normal honeycomb pattern of ureteric bud branching, single ureters entering the bladder (white dot), and separation
of Wolffian duct (wd) from the ureter was evident in kidneys (K) of mice expressing WT, RET51 and RET51(Y1062F). In RET51(Y1015F) animals, note
bilateral small kidneys with supernumerary UBs (arrows) that enter the mesenchyme but show decreased branching and failed to separate from the wd
(white dashed line). The testes (T) were also abnormally positioned. Bottom: Imaging of the above kidneys by confocal microscopy clearly depicts the
dramatic deficit in branching morphogenesis (arrowheads indicate branch points) in homozygous RET51(Y1015F) kidneys. Scale bar: 100 μm. Adapted
and modified from Jain et al.42 with permission.
184
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include activating factors upstream, either
in the MM or in mesonephric mesoderm
influencing Ret activity through Gdnf or
in the UB, and downstream of Ret such
as Wnt11 (forms a positive feedback loop),
and repressors such as Spry in the WD
or metanephros.45 I will briefly review
examples where direct evidence of genetic
interactions between Ret signaling complex and other genes has been observed
in vivo. One of the first examples of this
came from studies of Spry1 null and Gdnf
heterozygous animals. Without Spry1,
mice develop a CAKUT phenotype with
features of bilateral megaureters, gonadal
abnormalities and multiplexed hypoplastic/dysplastic kidneys.46 Because these mice
have supernumerary ureters and Gdnf in
kidney organ cultures can induce extraneous UB budding and ectopic ureters, it
was suggested that perhaps Gdnf was aberrantly expressed leading to the observed
phenotype. Further support for this concept comes from several mouse mutants
that have supernumerary ureters due to
failure to limit Gdnf expression to posterior IM.47,48 However, Basson et al. did not
detect abnormal anterior Gdnf expression
in the IM in Spry1 null mice suggesting
that WD in the Spry1 null mice is more
responsive to Gdnf. They supported this
idea by breeding Spry1 homozygous mice
onto Gdnf heterozygous background
and found that in a majority of double
homozygous/heterozygous, the CAKUT
phenotype appears to normalize, meaning Gdnf haploinsufficiency almost cures
CAKUT in Spry1 null mice.46 Basson et
al. also demonstrated that Spry1 signaling was important in kidney branching,
and this was dependent on Spry1 interactions with Gdnf-Ret signaling.49 However,
they showed that the mechanism of Spry1
interaction with the Ret pathway during
branching was different than its role in the
WD. In UB branching Gdnf expression
was much wider in MM in Spry1 nulls,
whereas in WD no increased or wider
Gdnf expression in the anterior IM was
noted. The increased Gdnf in MM was
likely due to increased Wnt11 expression in
UB as it induces Gdnf expression in MM.
Reducing Gdnf dosage also normalized the
branching defects in Spry1 null animals.
Spry proteins inhibit the MAPK
cascade.50 MAPK activation by Ret is
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primarily dependent on signals emanating from Ret-Y1062, a residue important
for UB induction. We tested whether the
Spry1 CAKUT phenotype will normalize in the background of RET9-Y1062F
mutants.51 We observed that double
homozygous Spry1:RET9-Y1062F mutant
mice have essentially normal kidneys providing in vivo evidence that Ret and Spry1
genetically interact (Fig. 6).
This result has several important implications. First, the ability to normalize two
remarkably different defects, renal agenesis in RET9-Y1062F and the complex
CAKUT phenotype in Spry1 null, by
expressing them in the same genetic background may be applicable in correcting
these disparate defects in fetuses by modulating these individual signaling pathways.
Second, it provides evidence for the importance of negative regulators in controlling RTK-mediated kidney development.
Third, it provides support to the possibility that RTKs other than Ret that may
play a role in kidney development but are
normally repressed by Spry1 (see below).
Studies from Basson et al. and Rozen et al.
provide a model where without Spry1, there
is RTK overdrive that leads to extra UB
outgrowths especially in the mesonephric
duct. This is mainly dependent on signals
from Ret-Y1062 which in the presence of
wild-type levels of Spry1 are somewhat
dampened in the anterior WD and therefore do not produce supernumerary ureters. Without Spry1, Ret-Y1062 dependent
activation of MAPK is at a much higher
level producing ectopic ureters since abrogation of Ret-Y1062 signaling in Spry1
null does not produce ectopic ureters. The
fact that UB normally grows from distal
WD in double Ret9-Y1062F: Spry1 null
animals suggests that other RTKs or other
Ret-dependent signaling pathways must
be compensating in these double mutants
to produce normal kidneys since the main
inducer of UB, Ret-Y1062 signaling, has
been abrogated (Fig. 6). One of these
pathways appears to be Fgf signaling. The
role of signaling by Fgf receptors as an
alternate pathway for early UB outgrowth
was suggested by studies where aberrant
expression of soluble Fgfr2IIIb resulted in
renal agenesis.52 Chi et al. demonstrated
interactions between Gdnf, Fgf7, Wnt11
and Spry signaling by showing that renal
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agenesis in transgenic mice expressing
human SPRY2 in the UB could be rescued
by Gdnf or Fgf7, supporting that Fgf signaling has the potential for stimulating
UB and branching.45 Recently, Maeshima
et al. showed that Fgf7, induced UB outgrowth in Ret null WDs when activin
signaling was inhibited.53 Conclusive evidence for participation of other RTKs
in the network of Ret-Spry1 in the early
events of WD growth to sculpt the metanephric kidney would require generation
of multiple mutant alleles including Fgf
pathway mutants, Spry1 and Ret signaling
mutants.
An important observation from the
Spry1:RET9-Y1062F mice is that the kidney defects were normalized but the intestinal aganglionosis was not (Fig. 6). So
in essence these double mutants manifest
as HSCR only even though they harbor
detrimental mutations in RET known to
severely affect kidney development when
present in isolation. Thus, depending on
the combination of the RET and SPRY1
mutations inherited/expressed, one could
be predisposed to CAKUT alone (SPRY1
deficiency), renal agenesis and HSCR
(RET9-Y1062F mutant), or HSCR alone
(double Spry1;Ret homozygous mutant
mice). These organ specific genetic interactions may explain some cases of HSCR
where RET mutations in the cytoplasmic
domain may not have any overt renal
anomalies or the basis for coexistence of
CAKUT and HSCR. It would be important to delineate other putative modifiers
of Ret mutant phenotypes to get a better understanding of organ specificity in
disease manifestation. Further, because of
possible genetic interactions, patients with
any of the diseases related to RET, such
as HSCR, MEN2 or CAKUT, presenting alone or in combination, may benefit
by screening for mutations in RET and
other genes that modify RET’s biological
responses.
Genetics of CAKUT
Recent advances in genetics and analysis of
a number of gene-deficient mouse models
that lead to renal malformation have led
investigators to examine the implications
of their findings in humans with CAKUT.
These studies point to strong associations
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Figure 6. Genetic interactions between Ret and Sprouty1 (Spry1) are specific to kidney. (A) Loss of Sprouty1 rescues renal defects found in animals
expressing Ret9 Y1062F. Whole mount of genito-urinary tracts from newborn mice of the indicated genotypes. Note that compared to individual
Ret9-Y1062F or Spry1-/-, the double Ret9-Y1062F:Spry1-null mice have essentially normal appearing kidneys and ureters. Thus, both the agenesis and
complex CAKUT phenotypes are rescued when these mutations are in the same background. (B) Lack of effect of Spry1 deficiency on the enteric innervation defects observed in RetRET9(Y1062F/Y1062F) mice, as revealed by whole mount acetylcholine esterase activity of digestive tracts from newborn mice.
Thus, in the enteric nervous system Spry1 does not interact with Ret as it is not able to rescue Hirschsprung disease phenotype in Ret-Y1062F mutants. Adapted and modified from Rozen et al. 51 with permission. (C–F) Model summarizing Ret-Spry1 interactions in the kidney. In normal situations,
Ret-activated cascades and Spry1 inhibition on Ret and other RTKs is in correct balance leading to normal kidneys (C). In absence of Ret-Y1062 signals,
the main residue that determines UB outgrowth, kidneys don’t develop; other RTKs cannot compensate as Spry1 is still inhibiting them (D). Without
Spry1, Ret-MAPK inhibition is gone leading to perhaps enhanced Ret-Y1062-MAPK signaling, as is also from other RTKs that may have the potential to
influence UB growth, thus leading to multiple ectopic UBs from the WD (E). In the absence of both Spry1 and Ret-Y1062, normal kidneys are observed
because, other RTKs or other Ret-Tyr can potentially activate UB growth mechanisms in distal WD as repression from Spry1 is absent; ectopic UBs
are not seen since RetY-1062 is the major signaling mechanism for UB growth in anterior WD.

between genes deemed important from animal studies and the identification of mutations in these in CAKUT. For example,
Robo2 disruption results in megaureters
with distal obstruction and dysplastic kidneys.47 Sequencing of ROBO2 in CAKUT
samples identified a subset of VUR patients
with mutations that disrupt ROBO2
function.54 Other genes that have roles in
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urinary system development and have been
found to be associated with mutations in
patients with isolated kidney defects or in
syndromes include BMP4, FOXC1, ACE,
Chr13q33-34, GATA3, PAX2, EYA1,
SAL1 and SIX1.55-58 Animal studies have
indicated that many of these influence
Gdnf-Ret signaling. Recently, RET coding region mutations were identified in 12
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of 33 patients with unilateral or bilateral
agenesis.2 Several of these were in cytoplasmic domain of RET suggesting that
decreased RET activity in humans results
in renal agenesis, as in the numerous Retmutant animals discussed above. Since animal studies now suggest a much larger role
of RET in CAKUT, further investigations
in larger human cohorts and in a broader
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Figure 7. Many faces of Ret dysfunction in kidney. Schematic shows the major key Ret docking tyrosine and the preferred activated pathways. Also,
depicted are the roles of these in the major processes of kidney development and examples of the phenotypes that are seen due to defects in these
processes. The spectrum of phenotypes in Ret mutants are shown. Note that influence of other modifier genes such as Spry1 or Gdnf can give combination of intermediate phenotypes that are not represented here. Thus, alterations in Ret signaling pathways by changes in overall expression, or
individual cascades. or through other genes encompasses majority if not all of CAKUT phenotypes. Parts of this figure are adapted from Jain et al.40,42
with permission.

spectrum of CAKUT would be needed to
determine the incidence of RET mutations
in these malformations, and more importantly where or what function of RET is
affected in these mutations. Since RET has
pleiotropic roles in human diseases including HSCR, MEN2 syndromes, patients
presenting with RET mutations in these
conditions should be closely monitored for
renal defects. CAKUT patients should be
monitored for HSCR phenotype as RET
intergenic interactions with its positive
and negative regulators can influence organotypic specificity of disease manifestation
(Fig. 7).
Conclusion
Since the initial discovery that Ret is
essential in kidney genesis almost fifteen
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years ago, efforts of several laboratories
have markedly enhanced our understanding of the roles of Ret signaling complex
in urinary system development. These
efforts have defined new roles of Ret in
kidney development through analyses of
hypomorphic or defined Ret-signaling
mutants and helped characterize how variations in amounts or type of Ret signaling can result in a wide array of CAKUT
phenotypes. Besides delineating specificity of Ret-dependent cascades and other
positive and negative regulators of Ret
in kidney development, the efforts have
led to a better understanding of the basic
processes of branching morphogenesis,
reciprocal interactions, cell proliferation,
migration, differentiation and survival,
and above all, of kidney and lower urinary tract development. New roles of Ret
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in distal ureter maturation have been discovered, and insights derived that explain
how complex phenotypes that encompass
distal ureter abnormalities such as megaureter/hydroureter and defects such as
renal hypoplasia or dysplasia can develop
either together as seen in Ret-Y1015F-Plcγ
mutant mice or in isolation as seen in Ret
hypomorphic mice. Experiments with
genes modifying Ret phenotypes have
also provided information that depending
on the context, upper and lower urinary
tract abnormalities can be detected singly, or together. The relevance of findings
from animal Ret mutant models was confirmed by the discovery of high incidence
of RET mutations in patients with kidney
agenesis.
While significant strides have been
made in our understanding of Ret biology
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and kidney development, several aspects
remain to be explored. For example, developmental processes that lead to the complex phenotypes in Ret mutants remain to
be defined particularly the events during
mesonephric kidney development. Also,
it must be determined what specific signals regulate ureter maturation. Since
many mutants in positive and negative
regulators produce the same phenotypes
as Ret mutants, studies that examine
which of these interact with Ret in vivo
need to be conducted in order to determine which pathways in kidney development converge and which interactions are
relevant in kidney versus in other organs
that are dependent on Ret for development. Specific questions that should be
addressed include the following: Is there
specificity of Spry proteins in kidney versus gut development? Do other genes such
as Slit2, Bmp4, Foxc1 interact with any
of the specific Ret cascades? What are the
relevant molecules downstream of Ret
that modulate kidney development? Are
there any positive or negative feedback
mechanisms that are important?
Ret continues to be expressed in developing kidney post-UB induction. Its
expression pattern changes from being
ubiquitous in the urinary tree to more
focal. Deciphering the transcriptome of
this Ret-positive population in temporal
manner in order to delineate the global
changes that occur in these progenitors as
kidney development proceeds could identify new molecules that may have important roles in kidney development. Further,
studies need to address if developmentally
important genes such as Ret have roles in
regeneration of adult kidney after injury as
increasingly it is being found that molecular signals that are important during early
development may have roles in regenerating damaged kidneys after injury.
Defining molecular aberrations leading to CAKUT in Ret mutant animals
and in humans will uncover biomarkers
that can be used for the early diagnosis
of renal abnormalities in children. While
finding RET mutations in patients with
renal agenesis is certainly a big step in this
direction, larger scale studies encompassing a wide spectrum of CAKUT phenotypes, in different populations can define
clinically relevant mutations in RET and
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interacting genes. Further, whole genomewide studies are needed to discover multigenic causes of CAKUT that may not
be apparent from screening of individual
target genes.
Questions and Answers
Andrew Siedlecki MD, Instructor in
Medicine, Washington University School
of Medicine: When you breed the SPRY1
knock out with your RET knockout,
that results in an interesting rescue. Do
you have any idea whether or not there
is a proliferative pathway that SPRY1
is using as an alternative to the MAPK
kinase pathway, for instance the mTOR
pathway?
Sanjay Jain MD, PhD, Assistant
Professor of Medicine and Pathology,
Washington University School of
Medicine: I don’t know of studies where
Spry1 modulates mTOR pathway. What is
known from literature about SPRY1 is that
MAPK pathway inhibition is its major target.59 Initially, Spry members were shown
to inhibit Fgf signaling in lung, and more
recently evidence has been provided for
Spry inhibiting Ret and Fgf pathways in
the kidney.45-49 That is why we think that
Fgf signaling may play a role. Chi et al.45
also alluded to role of Spry proteins in
modulating pathways other than MAPK
in kidney, however, the molecular nature
of these have not been defined. Dr. Sanjay
Nigam from UCSD has also shown that if
you treat WD derived from Ret knockout
animals with FGF7 in presence of inhibitors of activin you can actually induce UB
outgrowth further supporting Fgf as an
alternate pathway.53
Jianghui Hou PhD, Assistant Professor
of Medicine, Washington University
School of Medicine: What is the biochemical basis for the RET signaling? It
seems that RET activates PI3 kinase and
MAPK kinase, but another kinase pathway upstream (SPRY1-raf) also activates
MAPK. What do you think is the phosphorylation site for MAPK kinase downstream of RET? Could it be different
from the other one and is that why there
are two different phenotypes?
Sanjay Jain: The question is about
this idea of convergence of many different cascades into these common
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signaling pathways. It has always been
in an interesting biological question why
that occurs. From experiments in vitro
it seems to be that they activate MAPK
in a similar fashion as the intracellular
adaptors that activate Ras-Raf-Erk1/2
are similar. The basis for specificity for
different RTKs in part comes from their
specific ligands or coreceptors or cell-type
specific expression patterns.60 Similarly,
Spry proteins are themselves regulated at
transcriptional and translational level by
RTKs, and in turn they can inhibit RasMAPK pathways activated by RTK. This
can also vary at cell-type leveI. Thus there
is potential for intra RTK as well as inter
RTK modulation of MAPK cascades.
Feng Chen PhD, Assistant Professor of
Medicine, Washington University School
of Medicine: It has been proposed in a
recent paper34 that migration of Wolffian
duct epithelial cells near the caudal part
of the Wolffian duct is involved in the
formation of the ureteric bud. That process depends on Ret activity. You describe
in some of your mutants the formation of
multiple budding sites and some are very
anterior to the normal site. Do you see
any abnormal cell movement associated
with the formation of the ectopic buds
and what do you think is the positional
determinant for these buds?
Sanjay Jain: We haven’t really looked at
migration in our Ret mutants in the kidney in detail. We do see an increased Ret
signal at the distal Wolffian duct before
the UB evaginates, which we believe is
due to increased proliferation. Studies
from the laboratory Dr. Constantini,
Columbia University, show this may be
due to migration of anterior WD cells in
this zone and epithelial rearrangements.34
We have not explored this phenomenon
in the ectopic UBs seen in our mutants.
Regarding the question of the extra budding from the mesonephric portion of the
Wolffian duct, we believe in these regions
Spry1 inhibition is likely overcome due to
increased Ret expression/signaling, thus
tipping the balance in favor of Ret activated MAPK pathways. This was shown
by Basson et al. who observed increased
MAPK activity in WD with ectopic
UBs,46 and in their studies in which
Spry1 deletion in UB causes accelerated
UB branching.49
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